• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    FAMAR CDMO- From early development to commercial manufacturing.

    TearClear Announces Positive Topline Results from CLEAR Phase 3 Study

    GLOBENEWSWIRE

    TearClear successfully initiates of TC-002 Latanoprost Ophthalmic Solution

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.